Royal Bank Of Canada Fortress Biotech, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.65 $56 - $131	202 Added 42.8%	674 $0
Q2 2023 Aug 14, 2023	BUY	$0.49 - $0.82 $231 - $387	472 New	472 $0
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $213 - $5,940	-270 Reduced 67.5%	130 $0
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $3,607 - $6,763	-4,509 Reduced 91.85%	400 $0
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $15,190 - $33,687	-12,250 Reduced 71.39%	4,909 $7,000

Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.65 $23,553 - $35,525	9,733 Added 131.07%	17,159 $43,000
Q3 2021 Nov 15, 2021	BUY	$2.82 - $3.7 $7,103 - $9,320	2,519 Added 51.33%	7,426 $24,000
Q2 2021 Aug 16, 2021	BUY	$3.5 - $5.48 $17,174 - $26,890	4,907 New	4,907 $18,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.